TEVA CLOZAPINE
Live / Registered — Registered and renewed (as of 17 Sept 2021)
What this means for you
Registered since 17 May 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 May 2021).
Record
- Serial number
- 77969618
- Registration number
- 3960604
- Mark type
- Design + words
- Filed
- 26 Mar 2010
- Published for opposition
- 01 Mar 2011
- Registered
- 17 May 2011
- Next maintenance due
- 17 May 2021
- Attorney of record
- Lori Wolfe
Goods and services
- Class 005 — Pharmaceuticals: a full line of prescription pharmaceuticals featuring the ingredient clozapine
Owner
- Teva Pharmaceuticals USA, Inc., Parsippany, NJ, US
- Teva Pharmaceuticals USA, Inc., North Wales, PA, US
- Teva Pharmaceuticals USA, Inc., North Wales, PA, US
Prior registrations
Prosecution history
- 04 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Feb 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 04 Feb 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 17 Sept 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 17 Sept 2021 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 17 Sept 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 17 Sept 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 May 2021 — TEAS SECTION 8 & 9 RECEIVED
- 17 May 2020 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 31 Oct 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 31 Oct 2017 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 31 Oct 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 Oct 2017 — TEAS SECTION 8 & 15 RECEIVED